Qing Lin
Qing Lin, Buffalo, NY US
Patent application number | Description | Published |
---|---|---|
20090186817 | PEPTIDE-PEPTIDASE INHIBITOR CONJUGATES AND METHODS OF USING SAME - Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders. | 07-23-2009 |
20100029554 | Composition and Methods for Treatment of Congestive Heart Failure - Provided herein is the use of GLP-1 molecules or agonists and analogs thereof, and the use of exendin molecules or agonists and analogs thereof, including their derivatives and active fragments, for the prevention or treatment of congestive heart failure. Pharmaceutical compositions for use in the methods described herein are also disclosed. Further provided are compositions and methods for the treatment and/or prevention of diabetes mellitus, hyperglycemia, insulin resistance and obesity, and for the reduction of food intake and suppression of appetite of subjects. | 02-04-2010 |
20100292172 | Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same - Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders. | 11-18-2010 |
20140371148 | PEPTIDE-PEPTIDASE INHIBITOR CONJUGATES AND METHODS OF USING SAME - Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders. | 12-18-2014 |
Qing Lin, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100286365 | PEPTIDE-PEPTIDASE-INHIBITOR CONJUGATES AND METHODS OF MAKING AND USING SAME - Peptide-peptidase inhibitor conjugate molecules and methods of manufacture thereof are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders. | 11-11-2010 |
Qing Lin, Getzville, NY US
Patent application number | Description | Published |
---|---|---|
20080274952 | Amylin Family Peptides And Methods For Making And Using Them - The present invention relates to obesity related polypeptides (ORPs), related nucleic acids, expression constructs, host cells, and processes production of the obesity related polypeptides. The ORPs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk. | 11-06-2008 |
20080305519 | Biochemical method for specific protein labeling - An improved method for protein labeling comprising the steps of providing a synthetic small molecule tag, providing a target protein to be tagged, providing at least two enzymes for catalyzing a conjugation reaction between the tag and the target protein, incubating the tag, the protein and the enzyme, and allowing the tag to conjugate to the target protein. The tag may embody at least one structural feature of an ubiquitin C-terminus, and the structural feature may comprise a recognition sequence that is recognizable by an ubiquitin activating enzyme. | 12-11-2008 |
20100093086 | Stapled Peptides and Method of Synthesis - A method for preparing stapled peptides. The stapled peptides, including helical stapled peptides, are prepared according to a photochemically-based method, a [3+2] cycloaddition reaction. The helical stapled peptides exhibit increased helicity, thermal stability and cell permeability. | 04-15-2010 |
20120196796 | AMYLIN FAMILY PEPTIDES AND METHODS FOR MAKING AND USING THEM - The present invention relates to novel compounds having a function of a peptide in the amylin family, related nucleic acids, expression constructs, host cells, and processes production of the compounds. The compounds of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk. | 08-02-2012 |
20140057857 | Cross-Linked Peptides and Proteins, Methods of Making Same, and Uses Thereof - Cross-linked proteins and peptides, and methods of making and uses of such cross-linked proteins and peptides. The cross-linked proteins and peptides have rigid, distance-matching bismethylene aryl cross-linking moieties. Compositions comprising the cross-linked proteins and peptides can be used as pharmaceutical delivery formulations. The cross-linked proteins and peptides can have improved properties, such as cell permeability, as compared to the parent protein or peptide. | 02-27-2014 |
Qing Lin, Beijing CN
Patent application number | Description | Published |
---|---|---|
20090046606 | Adaptive Frame Structure for TDD Point-to-Point Wireless Transmission - The present invention relates to an arrangement for point-to-point transmission over links between first and second link (end) terminals in a system implementing time division duplex (TDD) and wherein information is sent over the links in frames divided into time slots. It is adapted to determine the lengths of the frames on a per link basis using one or more link parameters, the frame length hence being variable. | 02-19-2009 |
20090117108 | Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody - The invention is related to a recombinant single-chain tri-specific antibody made from anti-Tumor Associated Antigen (TAA) antibody, FC interlinker, anti-CD3 antibody, HSA interlinker and anti-CD28 antibody in turn. Particularly, the invention relates to an anti-CEA, anti-CD3, anti-CD28 recombinant single-chain tri-specific antibody, CEA-scTsAb, which was constructed with three tandem antibody fragments (anti-CEA scFv, anti-CD3 scFv and anti-CD28 single-domain antibody) linked by two interlinkers (FC interlinker, HSA interlinker), and could be appended by C myc tag or histidine tag ((His) | 05-07-2009 |
20120266325 | Plant Stress Tolerance Related Protein GmSIK1 and Encoding Gene and Use Thereof - Provided are a plant stress tolerance related protein GmSIK1 and encoding gene and use thereof. The GmSIK1 protein has the amino acid sequence as shown in SEQ ID NO: 2. The transgenic plant with enhanced stress tolerance such as drought tolerance and/or salt tolerance can be obtained from introducing the encoding gene of GmSIK1 protein into plant cell. | 10-18-2012 |
20120272352 | Genes Conferring Drought and Salt Tolerance and Uses Thereof - Compositions and methods for conferring drought and salt tolerance to plants using tocopherol cyclase (TC) genes, including polynucleotides, polypeptides, vectors, cells and plants. | 10-25-2012 |
20130014289 | GENES CONFERRING STRESS TOLERANCE IN PLANTS AND USES THEREOF - Compositions and methods for imparting stress tolerance to plants using WRKY nucleic acid and polypeptides. | 01-10-2013 |
Qing Lin, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090041458 | PASSIVE OPTICAL NETWORK SYSTEM MANAGEMENT - A passive optical network (PON) system utilizing a data link layer protocol for communication is disclosed. The PON system may include an optical network unit (ONU). The PON system may also include an optical line terminal (OLT) configured to communicate with the ONU utilizing an Ethernet frame. The Ethernet frame may include at least a source application identifier and a destination application identifier. The source application identifier may represent a source application residing in at least one of the OLT and the ONU. The destination application identifier may represent one or more destination applications configured to receive data from the source application. | 02-12-2009 |
Qing Lin, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20080241223 | EXTENDED RELEASE BIODEGRADABLE OCULAR IMPLANTS - Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer. | 10-02-2008 |
20130087270 | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS - Methods for making coatings on an implantable device such as a drug-eluting stent comprising a polymer and nano or microparticles of a drug in slow-dissolving polymorph, implantable devices produced by the methods and methods of using the coatings are provided. | 04-11-2013 |
20130142939 | Methods of Forming Coatings with a Crystalline or Partially Crystalline Drug for Implantable Medical Devices using Sonocrystallization - Methods for making coatings on an implantable device such as a drug-eluting stent comprising a polymer and nano or microparticles of a drug in slow-dissolving polymorph, implantable devices produced by the methods and methods of using the coatings are provided. | 06-06-2013 |
20130149430 | Methods of forming coatings with a crystalline or partially crystalline drug for implantable medical devices using supercritical fluid assisted sorption - Methods for making coatings on an implantable device such as a drug-eluting stent comprising a polymer and nano or microparticles of a drug in slow-dissolving polymorph, implantable devices produced by the methods and methods of using the coatings are provided. | 06-13-2013 |
20130149431 | Methods of Forming Coatings with a Crystalline or Partially Crystalline Drug for Implantable Medical Devices - Methods for making coatings on an implantable device such as a drug-eluting stent comprising a polymer and nano or microparticles of a drug in slow-dissolving polymorph, implantable devices produced by the methods and methods of using the coatings are provided. | 06-13-2013 |
20140035184 | EXTENDED RELEASE BIODEGRADABLE OCULAR IMPLANTS - Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer. | 02-06-2014 |
20150209276 | EXTENDED RELEASE BIODEGRADABLE OCULAR IMPLANTS - Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer. | 07-30-2015 |
Qing Lin, Shenzhen CN
Patent application number | Description | Published |
---|---|---|
20120127873 | METHOD, APPARATUS, AND SYSTEM FOR AUTOMATICALLY SWITCHING SERVICES - A method, an apparatus, and a system for automatically switching services are provided. The method includes: determining whether a switching condition is satisfied; migrating a user equipment (UE) using a first service operated on a switchable frequency point to a frequency point operating the first service, when the switching condition is satisfied; and switching the first service operated on the switchable frequency point to a second service. It is determined that a switching condition is satisfied, a UE using a first service operated on a switchable frequency point is migrated to a frequency point operating the first service, so as to switch the first service operated on the switchable frequency point to a second service, thereby improving utilization of spectrum resources and increasing a service income. | 05-24-2012 |
Qing Lin, Guangzhou CN
Patent application number | Description | Published |
---|---|---|
20130259809 | USE OF POLYSACCHARIDES FROM RADIX ISATIDIS IN MANUFACTURE OF MEDICAMENTS AGAINST INFLUENZA VIRUS - A process of using | 10-03-2013 |
Qing Lin, Freemont, CA US
Patent application number | Description | Published |
---|---|---|
20140249123 | EXTENDED RELEASE BIODEGRADABLE OCULAR IMPLANTS - Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer. | 09-04-2014 |
Qing Lin, Metz FR
Patent application number | Description | Published |
---|---|---|
20160032080 | LIQUID (METH)ACRYLIC SYRUP FOR IMPREGNATING A FIBROUS SUBSTRATE, METHOD OF IMPREGNATING A FIBROUS SUBSTRATE, COMPOSITE MATERIAL OBTAINED FOLLOWING POLYMERISATION OF THE PRE-IMPREGNATED SUBSTRATE - The present invention relates to a liquid (meth)acrylic syrup for impregnating a fibrous substrate. The present invention relates in particular to a viscous liquid syrup mainly containing methacrylic or acrylic components. The invention also relates to a process for manufacturing such a syrup. The invention also relates to a process for impregnating a fibrous substrate or long fibers with said viscous liquid syrup. The invention also relates to a fibrous substrate preimpregnated with said syrup, which is useful for manufacturing mechanical or structured parts or products. | 02-04-2016 |
Qing Lin, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20160106710 | WOUND HEALING VIA AUTOLOGOUS STEM CELL MOBILIZATION - The present invention relates to the field of wound healing. More specifically, the present invention provides methods and compositions useful for improved wound healing via autologous stem cell mobilization. In one embodiment, a method for improving wound healing in a patient comprises administering to the patient a therapeutically effective amount of a stem cell mobilizer and a low dose of an immunosuppressive agent. | 04-21-2016 |